The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2016 | A free market and data-driven approach to solve the issue of drug cost
Rafael Fonseca, MD from the Mayo Clinic, Scottsdale, AZ discusses the cost of drugs in multiple myeloma (MM) and the debate around the issue. According to Prof Fonesca, the costs associated with drug development have to be accounted for and a more data-driven and free market approach are needed to solve the issue of drug affordability.
Recorded at the American Society of Oncology (ASCO) 2016 Annual Meeting held in Chicago, IL.
